Leukemia Clinical Trials

Showing 4501-4520 of 10,987 trials

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

NCT05689619

This study aims to evaluate the efficacy of silibinin in preventing recurrence in the brain after complete resection of a brain metastasis (BM) from non-small-cell lung cancer (NSCLC) or breast cancer (BC).

Brain Metastases, AdultNon Small Cell Lung CancerBreast Cancer

A.O.U. Città della Salute e della Scienza70 participantsStarted Sep 2023

Genova, Italy • Messina, Italy • Rome, Italy +3 more locations

UNKNOWNPhase 2

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

NCT06171074

This study is a multicenter, single arm phase II clinical study mainly evaluating the efficacy of CM310 in patients with seasonal allergic rhinitis.

Seasonal Allergic Rhinitis

Keymed Biosciences Co.Ltd100 participantsStarted Mar 2024

Beijing, China

COMPLETEDPhase 2

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03014648

This is a phase II clinical trial aimed at evaluating the efficacy of PD-L1 inhibition with atezolizumab in advanced squamous and non-squamous NSCLC patients previously treated with anti-PD-1 therapy with either nivolumab or pembrolizumab. In order to account for the variability of response kinetics to PD-1 directed therapy, patients will be enrolled in 3 parallel cohorts based on the best overall response to PD-1 directed therapy. * Cohort 1 (progressive disease) * Cohort 2 (stable disease with minimum 12 weeks of therapy) * Cohort 3 (partial to complete response followed by progressive disease)

Advanced Non-small Cell Lung Cancer

Liza Villaruz, MD28 participantsStarted Jul 2017

Orlando, Florida, United States • Pittsburgh, Pennsylvania, United States

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Study of CM310 in Subjects With Seasonal Allergic Rhinitis

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

Related Searches

Nordic Walking to Manage Falls and Fear of Falling

To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray

A Study of Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

Empirical Versus Preemptive Antifungal Therapy

CREATE: Cross-tumoral Phase 2 With Crizotinib

A Follow-up Study With Children Who Participated in the TEMPO Study in Their First Year of Life

A Study of PRT2527 in Participants With Advanced Solid Tumors

A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula

The Role of NK Cells to Detect Blood Infection in ALL.

Reduction of Peanut Reactivity and Immune Modulation With Anti-IgE Therapy

Neurally Adjusted Ventilatory Assist for Weaning From Invasive Mechanical Ventilation in Critically Ill Children

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Optimal Extent of Pulmonary Resection in Clinical Stage IA Non-Small Cell Lung Cancer

Therapeutic Alliance and Treatment Outcome